JP6436985B2 - 動作可能な範囲設定技術を持つ分析物測定器 - Google Patents
動作可能な範囲設定技術を持つ分析物測定器 Download PDFInfo
- Publication number
- JP6436985B2 JP6436985B2 JP2016523787A JP2016523787A JP6436985B2 JP 6436985 B2 JP6436985 B2 JP 6436985B2 JP 2016523787 A JP2016523787 A JP 2016523787A JP 2016523787 A JP2016523787 A JP 2016523787A JP 6436985 B2 JP6436985 B2 JP 6436985B2
- Authority
- JP
- Japan
- Prior art keywords
- value
- meal
- post
- range
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title description 14
- 238000005516 engineering process Methods 0.000 title description 3
- 235000012054 meals Nutrition 0.000 claims description 61
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 46
- 239000008103 glucose Substances 0.000 claims description 46
- 238000000034 method Methods 0.000 claims description 31
- 238000005259 measurement Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 11
- 230000000291 postprandial effect Effects 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 8
- 239000010410 layer Substances 0.000 description 18
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000000875 corresponding effect Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002265 redox agent Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7475—User input or interface means, e.g. keyboard, pointing device, joystick
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/04—Constructional details of apparatus
- A61B2560/0431—Portable apparatus, e.g. comprising a handle or case
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/157—Devices characterised by integrated means for measuring characteristics of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/742—Details of notification to user or communication with user or patient ; user input means using visual displays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Physiology (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Emergency Medicine (AREA)
- Electrochemistry (AREA)
- Primary Health Care (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Artificial Intelligence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
Description
範囲のカスタム化は、次に、範囲インジケータが、現在の血液グルコース(「BG」)測定値又は測定数値が、別々のしるし(例えば、色)をコード化した基準と参照されるとき、所望の範囲設定(所望の範囲よりも高い又は範囲内である又は範囲よりも低いかどうか)に関連するところをより正確に示すことを可能にする。
(1)ユーザが、範囲の「下限」未満の範囲の「上限」を設定しようと試みる場合、「下限」値は、「上限」が「下限」よりも大きいことを確実にするように「上限」未満の1つの値の分、自動的に減少される。これは、「下限」値が最大許容低値に達するまで続く。他方では、ユーザが「下限」を「上限」よりも高く設定した場合、「上限」値は、最大許容「上限」値に達するまで、「下限」よりも大きい1つの数の分、自動的に増加される。
(2)「食後下限」を食前「下限」よりも低く設定することはできない。ユーザがそのように設定しようと試みた場合、警告メッセージが生成され、ユーザは、食前「下限」よりも大きい値に「食後下限」を再設定するように求められる。同様に、ユーザが「食前下限」を「食後下限」よりも高く設定しようとした場合、「食前下限」を「食後下限」未満の値に再設定するようにユーザに求める警告メッセージが生成される。
(3)「食後上限」を食前「上限」よりも低く設定することはできない。ユーザがそのように設定しようと試みた場合、警告メッセージが生成され、ユーザは、「食後上限」を食前「上限」よりも大きい値に再設定するように求められる。同様に、ユーザが食前「上限」を「食後上限」よりも高く設定しようとした場合、「食前上限」を「食後上限」未満の値に再設定するようにユーザに求める警告メッセージが生成される。
Claims (3)
- マイクロプロセッサ及び不揮発性メモリに動作可能に接続されるユーザインターフェース及びディスプレイを有するグルコース測定器を動作させる方法であって、前記方法は、
グルコース値の全体範囲にわたるグルコース値を定義するために、ユーザインターフェースを介して前記マイクロプロセッサに入力高値を入力する、工程と、
前記入力高値が、プリセットされた最小値未満の値として入力された場合、前記プリセットされた最小値は、前記マイクロプロセッサによって、前記入力高値よりも低いか、又は最小許容低値に等しい、新しい低値に変更される工程であって、前記新しい低値は、前記グルコース測定器の前記不揮発性メモリに記憶される、工程と、
入力低値が、プリセットされた最大値よりも大きいものとして入力された場合、前記プリセットされた最大値は、前記マイクロプロセッサによって、前記入力低値よりも大きいか、又は最大許容高値に等しい、新しい高値に変更される工程であって、前記新しい高値は、前記グルコース測定器の前記不揮発性メモリに記憶される、工程と、を含む、方法。 - マイクロプロセッサ及び不揮発性メモリに動作可能に接続されるユーザインターフェース及びディスプレイを有するグルコース測定器を動作させる方法であって、前記方法は、
食後に得たグルコース測定値に関連付けられたグルコース値の範囲を定義するために、食後最小値としての食後低値及び食後最大値としての食後高値のうちの少なくとも1つを、ユーザインターフェースを介して前記マイクロプロセッサに入力する、工程と、
前記食後低値が、食前最小値よりも低い値として入力された場合、エラーを通知し、前記食後低値を前記食前最小値よりも高い値に変更するように、前記ユーザインターフェースを介してユーザに要求する工程と、
前記食後高値が、食前最大値よりも低い値として入力された場合、エラーを通知し、前記食後高値を前記食前最大値よりも高い値に変更するように、前記ユーザインターフェースを介してユーザに要求する工程と、を含む、方法。 - マイクロプロセッサ及び不揮発性メモリに動作可能に接続されるユーザインターフェース及びディスプレイを有するグルコース測定器を動作させる方法であって、前記方法は、
食前に得たグルコース測定値に関連付けられたグルコース値の範囲を定義するために、食前最小値としての食前低値及び食前最大値としての食前高値のうちの少なくとも1つを、ユーザインターフェースを介して前記マイクロプロセッサに入力する、工程と、
前記食前低値が、食後最小値よりも高い値として入力された場合、エラーを通知し、前記食前低値を食後最小値未満の値に変更するように、前記ユーザインターフェースを介してユーザに要求する工程と、
前記食前高値が、前記食後最大値よりも高い値として入力された場合、エラーを通知し、前記食前高値を食後最大値未満の値に変更するように、前記ユーザインターフェースを介してユーザに要求する工程と、を含む、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/929,761 US9710604B2 (en) | 2013-06-27 | 2013-06-27 | Analyte meter with operational range configuration technique |
US13/929,761 | 2013-06-27 | ||
PCT/US2014/042640 WO2014209667A1 (en) | 2013-06-27 | 2014-06-17 | Analyte meter with operational range configuration technique |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016526680A JP2016526680A (ja) | 2016-09-05 |
JP2016526680A5 JP2016526680A5 (ja) | 2018-07-26 |
JP6436985B2 true JP6436985B2 (ja) | 2018-12-12 |
Family
ID=52116413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016523787A Active JP6436985B2 (ja) | 2013-06-27 | 2014-06-17 | 動作可能な範囲設定技術を持つ分析物測定器 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9710604B2 (ja) |
EP (3) | EP3216397B1 (ja) |
JP (1) | JP6436985B2 (ja) |
KR (1) | KR20160027039A (ja) |
CN (1) | CN105358060B (ja) |
AU (3) | AU2014302947A1 (ja) |
BR (1) | BR112015032315A2 (ja) |
CA (1) | CA2916654C (ja) |
HK (1) | HK1223531A1 (ja) |
RU (1) | RU2693360C2 (ja) |
WO (1) | WO2014209667A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015189761A1 (en) * | 2014-06-09 | 2015-12-17 | Sabic Global Technologies B.V. | Thermal conductive compositions having good impact performance |
US11035818B2 (en) * | 2014-08-15 | 2021-06-15 | Roche Diabetes Care, Inc. | Blood glucose meter with low cost user interface having programmed graphic indicators |
US12023180B1 (en) * | 2020-03-25 | 2024-07-02 | Miller Ip Law, Llc | Device and system user interfaces for chronic health condition management |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050022274A1 (en) * | 2003-04-18 | 2005-01-27 | Robert Campbell | User interface for infusion pump remote controller and method of using the same |
EP1893079B1 (en) * | 2005-06-08 | 2012-06-27 | SHER, Philip Michael | Fluctuating blood glucose notification threshold profiles and methods of use |
US20070016449A1 (en) | 2005-06-29 | 2007-01-18 | Gary Cohen | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges |
CN2850518Y (zh) * | 2005-10-24 | 2006-12-27 | 北京软测科技有限公司 | 便携式糖尿病病情监测仪 |
JP2007117434A (ja) * | 2005-10-28 | 2007-05-17 | Matsushita Electric Ind Co Ltd | 生体信号測定値評価システム |
US20080172031A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having correction factors |
IL197532A0 (en) * | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
JP5677321B2 (ja) | 2009-02-04 | 2015-02-25 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血糖コントロール用の情報を提供するための医療デバイス及び方法 |
JP5818691B2 (ja) | 2009-02-04 | 2015-11-18 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 血糖コントロールのための医療デバイス及び方法 |
CN102348414B (zh) * | 2009-03-16 | 2013-12-11 | 爱科来株式会社 | 连续测量基质浓度的方法 |
EP2455875A3 (en) * | 2009-06-30 | 2013-01-16 | Lifescan Scotland Limited | System and method for diabetes management |
JP5657678B2 (ja) * | 2009-09-29 | 2015-01-21 | ライフスキャン・スコットランド・リミテッドLifeScan Scotland, Ltd. | 糖尿病管理のための分析物試験方法及びデバイス |
CN102802522B (zh) * | 2010-02-25 | 2015-12-09 | 生命扫描苏格兰有限公司 | 具有胰岛素给药安全警告的分析物测试方法和系统 |
US8761940B2 (en) * | 2010-10-15 | 2014-06-24 | Roche Diagnostics Operations, Inc. | Time block manipulation for insulin infusion delivery |
US9903830B2 (en) | 2011-12-29 | 2018-02-27 | Lifescan Scotland Limited | Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte |
-
2013
- 2013-06-27 US US13/929,761 patent/US9710604B2/en active Active
-
2014
- 2014-06-17 BR BR112015032315A patent/BR112015032315A2/pt not_active Application Discontinuation
- 2014-06-17 CN CN201480036232.0A patent/CN105358060B/zh active Active
- 2014-06-17 WO PCT/US2014/042640 patent/WO2014209667A1/en active Application Filing
- 2014-06-17 EP EP17165557.4A patent/EP3216397B1/en active Active
- 2014-06-17 RU RU2016102319A patent/RU2693360C2/ru active
- 2014-06-17 EP EP14817890.8A patent/EP3013231A4/en not_active Ceased
- 2014-06-17 EP EP17165548.3A patent/EP3216396B1/en active Active
- 2014-06-17 KR KR1020167002195A patent/KR20160027039A/ko not_active Application Discontinuation
- 2014-06-17 JP JP2016523787A patent/JP6436985B2/ja active Active
- 2014-06-17 AU AU2014302947A patent/AU2014302947A1/en not_active Abandoned
- 2014-06-17 CA CA2916654A patent/CA2916654C/en active Active
-
2016
- 2016-10-13 HK HK16111835.8A patent/HK1223531A1/zh unknown
-
2019
- 2019-04-08 AU AU2019202444A patent/AU2019202444A1/en not_active Abandoned
- 2019-07-03 AU AU2019204797A patent/AU2019204797A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2693360C2 (ru) | 2019-07-02 |
US9710604B2 (en) | 2017-07-18 |
EP3216397B1 (en) | 2024-06-26 |
CN105358060B (zh) | 2019-03-08 |
EP3013231A4 (en) | 2017-07-19 |
KR20160027039A (ko) | 2016-03-09 |
HK1223531A1 (zh) | 2017-08-04 |
CA2916654A1 (en) | 2014-12-31 |
CN105358060A (zh) | 2016-02-24 |
AU2019204797A1 (en) | 2019-07-25 |
US20150006087A1 (en) | 2015-01-01 |
EP3216396B1 (en) | 2024-06-26 |
EP3216396A1 (en) | 2017-09-13 |
RU2016102319A (ru) | 2017-08-01 |
AU2014302947A1 (en) | 2016-01-28 |
WO2014209667A1 (en) | 2014-12-31 |
BR112015032315A2 (pt) | 2017-07-25 |
JP2016526680A (ja) | 2016-09-05 |
EP3013231A1 (en) | 2016-05-04 |
EP3216397A1 (en) | 2017-09-13 |
AU2019202444A1 (en) | 2019-05-02 |
CA2916654C (en) | 2022-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10058653B2 (en) | Smart sensor ports and methods of using same | |
JP6282229B2 (ja) | 検体を含む試料の検知された物理的特性により規定される複数の別個の測定値に基づいた電気化学的検査ストリップの正確な検体測定 | |
JP6100761B2 (ja) | 分析物試験ストリップに関するピークオフセット補正 | |
JP2013520672A (ja) | 電気化学的分析における静電容量の検出 | |
US20230075014A1 (en) | System and method for disease risk assessment and treatment | |
AU2019204797A1 (en) | Analyte meter with operational range configuration technique | |
JP6404927B2 (ja) | 液体試料のヘマトクリット非感受性グルコース値を測定する方法及びシステム | |
US20140275903A1 (en) | System and method for quick-access physiological measurement history | |
KR20140147849A (ko) | 이전의 생리적 측정치의 분석에 기초한 사용자에 대한 긍정적 강화 메시지 | |
RU2659345C2 (ru) | Способ и система для определения ошибочных измерительных сигналов во время последовательности тестового измерения | |
CA3148386C (en) | Contamination determination of biosensors used in analyte measurement systems | |
US9903879B2 (en) | Method to allow for linking temporal record with physiological measurement in buttonless physiological meters | |
US20140116893A1 (en) | System and method for reduction of perceived inaccuracy of analyte measurements | |
JP2016532114A (ja) | 試験測定シーケンス中に誤った測定信号を判定する方法及びシステム |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170509 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180302 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180313 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20180613 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180703 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181003 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181005 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181023 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181113 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6436985 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |